Current role
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2023-05-17–present
Kevin C. Gorman
Board Member
Neurocrine Biosciences Inc (NBIX)Equibles does not estimate personal net worth.
Get an email with a short summary when Neurocrine Biosciences Inc publishes a filing, an earnings call transcript or a press release.
Get NBIX alertsAbout Kevin C. Gorman
Kevin C. Gorman is recorded as Board Member at Neurocrine Biosciences Inc (NBIX) since May 17, 2023. The newest filing on record that lists Kevin C. Gorman as Board Member at Neurocrine Biosciences Inc (NBIX) is dated April 15, 2026. The proxy statement of Neurocrine Biosciences Inc reports total compensation of $16,018,637 for Kevin C. Gorman in fiscal 2024, including a base salary of $779,357. Disclosed compensation is on record for 8 fiscal years. Neurocrine Biosciences Inc is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Neurocrine Biosciences Inc includes Kevin Gorman (CEO and Board Member), Kyle Gano, Ph.D. (CEO and Board Member), Kyle W. Gano (CEO and Board Member) and 7 others.
Affiliation history
-
Current
2023-05-17–present
Last confirmed April 15, 2026
-
Start not stated–2024-04-10
Last confirmed by a filing; no departure on record
Company network
Leadership on record at Neurocrine Biosciences Inc
- Kevin Gorman CEO, Board Member
- Kyle Gano, Ph.D. CEO, Board Member
- Kyle W. Gano CEO, Board Member
- Matthew C. Abernethy CFO
- Christine A. Poon Board Member
- Gary A. Lyons Board Member
- George J. Morrow Board Member
- Johanna Mercier Board Member
- Kevin C. Gorman, Ph.D. Board Member
- Kyle W. Gano, Ph.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Neurocrine Biosciences Inc (NBIX) | Former Chief Executive Officer | $779,357 | $16,018,637 |
| 2023 | Neurocrine Biosciences Inc (NBIX) | Former Chief Executive Officer | $946,000 | $15,750,812 |
| 2022 | Neurocrine Biosciences Inc (NBIX) | Former Chief Executive Officer | $860,000 | $11,902,527 |
| 2021 | Neurocrine Biosciences Inc (NBIX) | Chief Executive Officer | $825,000 | $14,081,412 |
| 2020 | Neurocrine Biosciences Inc (NBIX) | Chief Executive Officer | $775,000 | $13,880,632 |
| 2019 | Neurocrine Biosciences Inc (NBIX) | Chief Executive Officer | $725,000 | $9,450,826 |
| 2018 | Neurocrine Biosciences Inc (NBIX) | Chief Executive Officer | $675,000 | $8,632,979 |
| 2017 | Neurocrine Biosciences Inc (NBIX) | Chief Executive Officer | $640,000 | $7,556,374 |
Recent activity
No call appearances or filed executive changes recorded yet.